56 studies found for:
graves
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 21 | Recruiting |
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
|
||||
| 22 | Unknown † |
Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
|
||||
| 23 | Completed |
Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients
|
||||
| 24 | Active, not recruiting |
A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
|
||||
| 25 | Completed |
Thyroid Treatment Trial
|
||||
| 26 | Unknown † |
Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
|
||||
| 27 | Recruiting |
Differential Diagnosis Value of PSV of Thyroid Superior Artery Using Color Flow Doppler Sonography in Transient Thyrotoxicosis
|
||||
| 28 | Unknown † |
Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy
|
||||
| 29 | Unknown † |
Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction
|
||||
| 30 | Completed |
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
|
||||
| 31 | Completed |
Antithyroid Drugs During Radioiodine Therapy
|
||||
| 32 | Completed |
Block-replacement Therapy During Radioiodine Therapy
|
||||
| 33 | Completed |
rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter
|
||||
| 34 | Active, not recruiting |
Trial of Rituximab for Graves' Ophthalmopathy
|
||||
| 35 | Completed |
Subtotal Versus Total Thyroidectomy for Graves' Disease
|
||||
| 36 | Recruiting |
Bupivacaine Injection of Eye Muscles to Treat Strabismus
|
||||
| 37 | Terminated |
Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy
|
||||
| 38 | Active, not recruiting |
Cervarix Long-term Safety Surveillance
|
||||
| 39 | Completed |
Is the Routine Pressure Dressing After Thyroidectomy Necessary?
|
||||
| 40 | Completed |
Predictive Genetic Risk Assessment Trial
|
† Indicates status has not been verified in more than two years

